Literature DB >> 27409979

How Similar Are the Disorders Included Under the Umbrella of Obsessive-Compulsive Disorder and Related Disorders?-Reply.

Eric W Leppink1, Samuel R Chamberlain2, Jon E Grant1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27409979      PMCID： PMC5325313          DOI： 10.1001/jamapsychiatry.2016.1452

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  5 in total

1.  N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.

Authors:  Jerome Sarris; Georgina Oliver; David A Camfield; Olivia M Dean; Nathan Dowling; Deidre J Smith; Jenifer Murphy; Ranjit Menon; Michael Berk; Scott Blair-West; Chee H Ng
Journal:  CNS Drugs       Date:  2015-09       Impact factor: 5.749

2.  N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial.

Authors:  K Paydary; A Akamaloo; A Ahmadipour; F Pishgar; S Emamzadehfard; S Akhondzadeh
Journal:  J Clin Pharm Ther       Date:  2016-03-02       Impact factor: 2.512

3.  N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial.

Authors:  Jon E Grant; Samuel R Chamberlain; Sarah A Redden; Eric W Leppink; Brian L Odlaug; Suck Won Kim
Journal:  JAMA Psychiatry       Date:  2016-05-01       Impact factor: 21.596

4.  N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.

Authors:  Hamid Afshar; Hamidreza Roohafza; Hamid Mohammad-Beigi; Mohammad Haghighi; Leila Jahangard; Pedram Shokouh; Masoumeh Sadeghi; Hasan Hafezian
Journal:  J Clin Psychopharmacol       Date:  2012-12       Impact factor: 3.153

5.  N-acetylcysteine Facilitates Self-Imposed Abstinence After Escalation of Cocaine Intake.

Authors:  Eric Ducret; Mickaël Puaud; Jérôme Lacoste; Aude Belin-Rauscent; Maxime Fouyssac; Emilie Dugast; Jennifer E Murray; Barry J Everitt; Jean-Luc Houeto; David Belin
Journal:  Biol Psychiatry       Date:  2015-10-08       Impact factor: 13.382
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.